We make a wide range of prescription medicines, vaccines and consumer healthcare products. Explore our three business area portfolios for more information. We list many – but not all – of our products on the following pages.

In March 2015 we completed a 3-part transaction with Novartis which reshaped our business.

We acquired Novartis’s vaccines business (excluding influenza vaccines) and combined our consumer healthcare businesses to create a new company.

In addition, Novartis acquired our marketed Oncology portfolio and the R&D activities related to it.